AI in Real-World Data analytics: capturing the value for drug development

Recording of keynote panel at BioData World Congress, Nov 2021, Basel, Switzerland

During this panel discussion, our speakers will talk through common applications of RWD in drug development, how AI/ML techniques in RWD analyses are helping patients, carers and policy makers to drive better patient outcomes, and challenges their organizations are working to solve related to the use of AI in RWD.

  • What are the biggest value drivers in using AI in RWD analyses?
  • What are some of the considerations around AI IP protection?
  • How can we as an industry capture the value of AI in drug development while adhering to global data privacy legislation?
  • What are some of the considerations around images and deploying AI for independently evaluating patient outcomes?
Jennifer Cubino Photo-1

Jennifer Cubino

COO, Customer Success & Data Science, BC Platforms

Iris Grossman
Iris Grossman

Chief Strategy Officer, Eleven Therapeutics

Tonu Esko
Tõnu Esko

Head of Estonian Biobank Innovation Center

Sanjoy Paul
Sanjoy Paul

Real World Evidence Leader – Oncology, AstraZencea

Maria Del Pilar Schneider

Maria Del Pilar Schneider
Senior Data Mining Statistician, IPSEN Innovation

Fill out this form to watch the Keynote Panel